Engineers Gate Manager’s Medifast MED Stock Holding History

Engineers Gate Manager’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$529K	Buy	49,829 +10,249	+26%	+$118K	0.01%	1474
2026 Q1	$403K	Buy	+39,580	New	+$427K	0.01%	1524
2025 Q3	–	Sell	-11,451	Closed	-$161K	–	2380
2025 Q2	$161K	Buy	+11,451	New	+$150K	﹤0.01%	1931
2025 Q1	–	Sell	-17,333	Closed	-$305K	–	2409
2024 Q4	$305K	Sell	17,333 -5,920	-25%	-$110K	0.01%	1689
2024 Q3	$445K	Sell	23,253 -9,625	-29%	-$185K	0.01%	1434
2024 Q2	$717K	Buy	+32,878	New	+$876K	0.02%	1056
2024 Q1	–	Sell	-7,227	Closed	-$486K	–	2146
2023 Q4	$486K	Sell	7,227 -17,298	-71%	-$1.21M	0.01%	1188
2023 Q3	$1.84M	Sell	24,525 -14,509	-37%	-$1.29M	0.07%	417
2023 Q2	$3.6M	Buy	39,034 +4,422	+13%	+$394K	0.14%	189
2023 Q1	$3.59M	Buy	34,612 +22,773	+192%	+$2.52M	0.15%	170
2022 Q4	$1.37M	Buy	11,839 +2,064	+21%	+$240K	0.08%	323
2022 Q3	$1.06M	Buy	+9,775	New	+$1.4M	0.07%	419
2022 Q2	–	Sell	-11,116	Closed	-$1.9M	–	2108
2022 Q1	$1.9M	Buy	11,116 +6,962	+168%	+$1.31M	0.07%	349
2021 Q4	$870K	Sell	4,154 -10,749	-72%	-$2.22M	0.04%	702
2021 Q3	$2.87M	Buy	14,903 +5,784	+63%	+$1.42M	0.16%	129
2021 Q2	$2.58M	Sell	9,119 -2,544	-22%	-$689K	0.17%	126
2021 Q1	$2.47M	Buy	11,663 +9,325	+399%	+$2.23M	0.12%	199
2020 Q4	$459K	Sell	2,338 -9,321	-80%	-$1.65M	0.02%	1036
2020 Q3	$1.92M	Buy	11,659 +1,231	+12%	+$203K	0.09%	320
2020 Q2	$1.45M	Buy	10,428 +1,673	+19%	+$154K	0.07%	423
2020 Q1	$547K	Buy	+8,755	New	+$797K	0.04%	718
2018 Q3	–	Sell	-12,238	Closed	-$1.96M	–	1066
2018 Q2	$1.96M	Sell	12,238 -9,967	-45%	-$1.27M	0.15%	214
2018 Q1	$2.08M	Buy	+22,205	New	+$1.66M	0.14%	268

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Engineers Gate Manager's MED Position: Q2 2026 in Review

Engineers Gate Manager increased its Medifast (MED) stake by 26% in Q2 2026, buying an estimated $118K and bringing the position to 49,829 shares worth $529K. The position accounts for 0.01% of the portfolio, ranked #1474.

Engineers Gate Manager first reported a position in MED in Q1 2018 and has held it in 23 quarters since. The position peaked at $3.6M in Q2 2023. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Engineers Gate Manager held 49,829 shares of Medifast worth $529K as of Q2 2026.
Engineers Gate Manager bought 10,249 Medifast shares in Q2 2026, an estimated $118K.
Medifast made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1474 holding.
Engineers Gate Manager first reported a position in Medifast in Q1 2018 and has held it in 23 quarters since.
Engineers Gate Manager's Medifast position peaked at $3.6M in Q2 2023.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.